| Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis AGT Lucas, CA Lindemans, SV Bhoopalan, R Dandis, SE Prockop, ... Cytotherapy 25 (9), 977-985, 2023 | 10 | 2023 |
| Outcomes of patients who underwent treatment for anti‐HLA donor‐specific antibodies before receiving a haploidentical hematopoietic cell transplant A Lipsitt, P Arnold, L Chi, K Carruthers, S Folk, S Fossey, D Keerthi, ... Pediatric Blood & Cancer 69 (12), e29993, 2022 | 5 | 2022 |
| Effectiveness of bath wipes after hematopoietic cell transplantation: a randomized trial M Kjellin, A Qudeimat, E Browne, D Keerthi, A Sunkara, G Kang, ... Journal of Pediatric Oncology Nursing 37 (6), 390-397, 2020 | 3 | 2020 |
| Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning Y Zhou, J Smith, D Keerthi, C Li, Y Sun, SS Mothi, DC Shyr, B Spitzer, ... Blood Advances 8 (3), 686-698, 2024 | 2 | 2024 |
| Hematopoietic stem/progenitor cells and engineering: early CD4 T cell immune reconstitution after HCT is associated with reduced non-relapse related mortality but not with … AT Lucas, A Sharma, C de Koning, S Bhoopalan, D Keerthi, S Prockop, ... Cytotherapy 24 (5), S98, 2022 | 1 | 2022 |
| Exposure to Anti-Anaerobic Antimicrobials Around Hematopoietic Cell Transplant (HCT) Is Associated with Poor Outcomes in Pediatric Patients J Truscott, G Maron, D Hijano, D Keerthi, S Huang, C Cheng, A Sharma Blood 138, 2854, 2021 | 1 | 2021 |
| Pre-and post-magnetic resonance imaging of hips and knees for detecting osteonecrosis in children and adolescents undergoing hematopoietic cell transplantation S Kaste, AY Suliman, Y Li, D Keerthi, G Kang, B Triplett, A Srinivasan Bone Marrow Transplantation 55 (9), 1837-1839, 2020 | 1 | 2020 |
| Elevation of NT-proBNP Levels in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Patients with Endotheliopathy K Uchida, X Yuan, J McArthur, R Lassiter, H Pan, D Keerthi, K Tsai, ... Pediatric Reports 16 (4), 934-944, 2024 | | 2024 |
| EASIX and m-EASIX Predict CRS and ICANS in Pediatric and AYA Patients post CD19-CAR T cell Therapy S Selukar, Y Bi, Y Li, M Zinsky, CL Bonifant, R Epperly, D Keerthi, ... Blood Advances, 2024 | | 2024 |
| NT-proBNP as a Biomarker of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation K Uchida, X Yuan, J McArthur, R Lassiter, H Pan, D Keerthi, K Tsai, ... Preprints, 2024 | | 2024 |
| Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study S Suryaprakash, Y Bi, S Selukar, D Keerthi, A Qudeimat, AC Talleur, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease S Suryaprakash, Y Sun, L Tang, D Keerthi, A Qudeimat, AC Talleur, ... Transplantation and Cellular Therapy 30 (2), S401, 2024 | | 2024 |
| Real World Use of the Pediatric Disease Risk Index for Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: A … AGT Lucas, SV Bhoopalan, S Nierkens, C de Koning, D Keerthi, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Abstract Title: Cell & Gene Therapy Information Systems and Analytics Frameworkabstract Description: Implementing a Strong and Sustainable Information Systems and Analytics … D Keerthi Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| 1529: NT-PROBNP AS A BIOMARKER OF ENDOTHELIOPATHY IN PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION K Uchida, J McArthur, X Yuan, R Lassiter, H Pan, D Keerthi, K Tsai, ... Critical Care Medicine 52 (1), S735, 2024 | | 2024 |
| Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease S Suryaprakash, Y Sun, L Tang, D Keerthi, A Qudeimat, AC Talleur, ... Blood 142, 7042, 2023 | | 2023 |
| Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study S Suryaprakash, Y Bi, S Selukar, D Keerthi, A Qudeimat, AC Talleur, ... Blood 142, 7087, 2023 | | 2023 |
| Hematopoietic Stem/Progenitor Cells and Engineering: REAL WORLD USE OF THE PEDIATRIC DISEASE RISK INDEX FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE … AT Lucas, S Nierkens, C de Koning, R Dandis, D Keerthi, S Naik, ... Cytotherapy 25 (6), S136-S137, 2023 | | 2023 |
| Machine Learning Approaches Incorporating High-Dimensional Longitudinal Data Improve Survival Prediction after Allogeneic Hematopoietic Cell Transplantation J Smith, Y Zhou, D Keerthi, SS Mothi, DC Shyr, B Spitzer, A Chatterjee, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Early Lymphocyte Immune Reconstitution As Predictor for Outcomes after Allogeneic Hematopoietic Cell Transplantation for Malignant Indications; A Tri-Institutional Analysis AGT Lucas, CA Lindemans, SV Bhoopalan, R Dandis, SE Prockop, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
